Citrate level in osteoporotic women treated with estrogen and alendronate

被引：0
|
作者：
D'Amelio, P
Beccattini, W
Pescarmona, GP
Isaia, GC
机构：
[1] Univ Turin, Dept Gen Biol & Biochem, I-10124 Turin, Italy
[2] Univ Turin, Dept Internal Med, I-10124 Turin, Italy
来源：
OSTEOPOROSIS INTERNATIONAL | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
374
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of alendronate in the prevention of osteoporotic fractures in Danish women
    Christensen, PM
    Brixen, K
    Gyrd-Hansen, D
    Kristiansen, IS
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2005, 96 (05) : 387 - 396
  • [32] Alendronate improves the structural geometry of the proximal femur in postmenopausal osteoporotic women
    Beck, T. J.
    Cauley, J. A.
    de Papp, A. E.
    Wehren, L. E.
    Baran, D. T.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S73 - S73
  • [33] Alendronate improves the structural geometry of the proximal femur in postmenopausal osteoporotic women
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S163 - S163
  • [34] Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women
    Cosman, F
    Nieves, J
    Woelfert, L
    Shen, V
    Lindsay, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (06) : 1051 - 1055
  • [35] Alendronate increases trabecular bone connectivity in elderly osteoporotic women.
    Masarachia, P
    Howard, T
    Santora, A
    Yates, J
    Rodan, GA
    Recker, RR
    Kimmel, DB
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S372 - S373
  • [36] Dose-response relationships for alendronate treatment in osteoporotic elderly women
    Bone, HG
    Downs, RW
    Tucci, JR
    Harris, ST
    Weinstein, RS
    Licata, AA
    McClung, MR
    Kimmel, DB
    Gertz, BJ
    Hale, E
    Polvino, WJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01): : 265 - 274
  • [37] ALENDRONATE DISCONTINUATION IN POSTMENOPAUSAL WOMEN TREATED FOR OSTEOPOROSIS
    Powell, Diane
    Than, Soe Soe
    Butler, Robin
    Matthews, Clare
    Garton, Mark
    RHEUMATOLOGY, 2014, 53 : 133 - 134
  • [38] The Risk of Osteonecrosis of the Jaws in Taiwanese Osteoporotic Patients Treated With Oral Alendronate or Raloxifene
    Chiu, Wei-Yih
    Chien, Jung-Yien
    Yang, Wei-Shiung
    Juang, Jyh-Ming Jimmy
    Lee, Jang-Jaer
    Tsai, Keh-Sung
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (08): : 2729 - 2735
  • [39] THE RISK OF OSTEONECROSIS OF THE JAW IN TAIWANESE OSTEOPOROTIC PATIENTS TREATED WITH ORAL ALENDRONATE OR RALOXIFENE
    Chiu, W. -Y.
    Chien, J. -Y.
    Yang, W. -S.
    Juang, J. -M J.
    Lee, J. -J.
    Tsai, K. -S.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S430 - S431
  • [40] Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women
    Tonino, RP
    Meunier, PJ
    Emkey, R
    Rodriguez-Portales, JA
    Menkes, CJ
    Wasnich, RD
    Bone, HG
    Santora, AC
    Wu, M
    Desai, R
    Ross, PD
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09): : 3109 - 3115
12345